Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 196 articles:
HTML format



Single Articles


    August 2022
  1. JACOMINA LE, Eala MAB, Mejia MBA, Baldivia KH, et al
    Utilization of Hypofractionated Radiation Therapy for Breast Cancer: Perspectives From the Philippines.
    Int J Radiat Oncol Biol Phys. 2022;113:925-927.
    PubMed    


    July 2022
  2. SIMONETTO C, Kaiser JC, van den Bogaard VAB, Langendijk JA, et al
    Breast cancer radiotherapy and the risk of acute coronary events - insights from a process oriented model.
    Int J Radiat Oncol Biol Phys. 2022 Jul 1. pii: S0360-3016(22)00645.
    PubMed     Abstract available


  3. AL-RASHDAN A, Cao J
    A Viewpoint on Isolated Contralateral Axillary Lymph Node Involvement by Breast Cancer: Regional Recurrence or Distant Metastasis?
    Int J Radiat Oncol Biol Phys. 2022;113:489.
    PubMed    


  4. MAILHOT VEGA RB, Wang S, Brooks ED, Oladeru OT, et al
    Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.
    Int J Radiat Oncol Biol Phys. 2022;113:542-551.
    PubMed     Abstract available


  5. JACOBS DHM, Mast ME, Horeweg N, Speijer G, et al
    Accelerated Partial Breast Irradiation Using External Beam or Intraoperative Electron Radiation Therapy: 5-Year Oncological Outcomes of a Prospective Cohort Study.
    Int J Radiat Oncol Biol Phys. 2022;113:570-581.
    PubMed     Abstract available


    June 2022
  6. LAPEN K, King C, Braunstein LZ, Khan AJ, et al
    A Comparison of Patient- and Clinician-Reported Acute Toxicity During Radiotherapy for Primary Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 5. pii: S0360-3016(22)00548.
    PubMed     Abstract available


  7. DILWORTH JT, Griffith KA, Pierce LJ, Jagsi R, et al
    The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium.
    Int J Radiat Oncol Biol Phys. 2022;113:266-277.
    PubMed     Abstract available


    May 2022
  8. ZHANG L, Liu J, Ma J, Mei X, et al
    Entire versus Medial Supraclavicular Nodal Irradiation for Patients with High-risk Node-positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 May 30. pii: S0360-3016(22)00479.
    PubMed     Abstract available


  9. SHUKLA U, Sueyoshi M, Diamond B, Chowdhury I, et al
    Disparities in Radiation Therapy: Practice Patterns Analysis of Deep Inspiratory Breath Hold Use in Non-English Speakers.
    Int J Radiat Oncol Biol Phys. 2022;113:21-25.
    PubMed     Abstract available


    April 2022
  10. ZUREICK AH, Grzywacz VP, Almahariq MF, Silverman BR, et al
    Dose to the Left Anterior Descending Artery Correlates with Cardiac Events Following Irradiation for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 25. pii: S0360-3016(22)00332.
    PubMed     Abstract available


  11. DOSANI M, Hamilton S, Gondara L, Speers C, et al
    pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison to pN0 and pN1a in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2022 Apr 3. pii: S0360-3016(22)00275.
    PubMed     Abstract available


  12. MIGNOT F, Quero L, Guillerm S, Benadon B, et al
    Ten-Year Outcomes of Hypofractionated Postmastectomy Radiation Therapy of 26 Gy in 6 Fractions.
    Int J Radiat Oncol Biol Phys. 2022;112:1105-1114.
    PubMed     Abstract available


    March 2022
  13. ANDRING LM, Diao K, Sun S, Patel M, et al
    Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.
    Int J Radiat Oncol Biol Phys. 2022 Mar 3. pii: S0360-3016(22)00192.
    PubMed     Abstract available


  14. NICHOL A, Narinesingh D, Wade L, Raman S, et al
    Breast Tangent Beam Energy, Surgical Bed-to-Skin Distance and Local Recurrence After Breast-Conserving Treatment.
    Int J Radiat Oncol Biol Phys. 2022;112:671-680.
    PubMed     Abstract available


    February 2022
  15. VERBANCK S, Van Parijs H, Schuermans D, Vinh-Hung V, et al
    Lung Restriction in Breast Cancer Patients after Hypofractionated Tomotherapy and Conventional 3D Conformal Radiotherapy: a 10-year Follow-up.
    Int J Radiat Oncol Biol Phys. 2022 Feb 25. pii: S0360-3016(22)00167.
    PubMed     Abstract available


  16. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation.
    Int J Radiat Oncol Biol Phys. 2022;112:426-436.
    PubMed     Abstract available


  17. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.
    Int J Radiat Oncol Biol Phys. 2022;112:437-444.
    PubMed     Abstract available


    January 2022
  18. ABRAHAM A, Sanghera KP, Gheisari F, Koumna S, et al
    Is radiation-induced cardiac toxicity reversible? Prospective evaluation of breast cancer patients enrolled in a phase-III randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 24. pii: S0360-3016(22)00065.
    PubMed     Abstract available


  19. WARD MC, Bentzen SM, Fasola CE, Khan AJ, et al
    An Estimate of Local Failure in the TARGIT-A Trial of Pre-pathology Intraoperative Radiation Therapy for Early Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 19. pii: S0360-3016(21)03434.
    PubMed     Abstract available


  20. BELLON JR, Tayob N, Yang DD, Tralins J, et al
    Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 3. pii: S0360-3016(21)03446.
    PubMed     Abstract available


  21. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
    Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated with Radiation Therapy and Trastuzumab.
    Int J Radiat Oncol Biol Phys. 2022 Jan 2. pii: S0360-3016(21)03432.
    PubMed     Abstract available


  22. SHUMWAY DA, Corbin KS, Mutter RW
    Improving the Therapeutic Ratio Among Older Women With Early Stage Breast Cancer by Reevaluating Adjuvant Radiation Therapy and Hormone Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:52-55.
    PubMed    


    December 2021
  23. VICINI F, Broughman J, Halima A, Mayo Z, et al
    Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2021 Dec 15. pii: S0360-3016(21)03233.
    PubMed     Abstract available


    November 2021
  24. SIT D, Lalani N, Chan E, Tran E, et al
    Association between regional nodal irradiation and breast cancer recurrence-free interval for patients with low-risk, node-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Nov 8. pii: S0360-3016(21)03072.
    PubMed     Abstract available


  25. MA DC, Potters L, Lee L, Bloom BF, et al
    Patient-Reported Outcomes Using Automated Chatbot for Breast Cancer Patients Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  26. LIANG X, Li N, Zhou X, Jin H, et al
    Evaluation of Automated Breast Cancer Contour Propagation From Planning CT to Cone Beam CT Based on Deep Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  27. TAKAYESU J, Sapir E, Xie J, Sun Y, et al
    Survival Outcomes and Symptom Benefit From Palliative Radiotherapy in Breast Cancer Patients With Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  28. SHUMWAY JW, Torras M, Hayes KR, Jolly T, et al
    Outcomes of Patients With HER2-Positive Breast Cancer Metastatic to Brain Treated With HER2-Targeted Systemic Therapy and Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  29. MILLIGAN MG, Aitelli A, Mehan WA, Shi DD, et al
    Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  30. SAID BI, Chen H, Jerzak K, Myrehaug SD, et al
    T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  31. PERRON-GAGNON L, Archambault L, Varfalvy N, Piron O, et al
    Breast Deformations Measured With Cone Beam Computed Tomography During Adjuvant Radiotherapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  32. LEE JJB, Lee IJ, Choi Y, Jeon MJ, et al
    Clinical Implications of Geometric and Dosimetric Uncertainties Due to Inter- and Intra-Fractional Movement During Volumetric Modulated Arc Therapy for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  33. GIANTSOUDI D, Lalonde A, Colleen B, Vanbenthuysen L, et al
    Tattoo-Free Set-ups for Breast Cancer Patients Receiving Regional Nodal Irradiation: Evaluation of Accuracy and Time Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  34. XIN X, Zhang D, Zhao Y, Wang P, et al
    Overview of the Dosimetry of Free Breathing and Breath Hold Forward Intensity Modulated Treatments in a Large Clinical Series of Left-Sided Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  35. MURAKAMI Y, Murakami Y, Kamima T, Abo N, et al
    Dosimetric Comparison Between 3D Conformal Radiation Therapy Plus Electron Boost and Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Left-Sided Breast Cancer Patients With a Potential Risk of Radiation-Induced Cardiac Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  36. MLADKOVA N, Smith TL, Yildiz V, Healy E, et al
    The Impact of Bioabsorbable 3D Fiducial Marker on Radiation Dosimetry and Cosmesis in Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  37. FAIRCHILD AM, Hill J, Alhumaid M, Ghosh S, et al
    Palliative Radiotherapy Delivery by a Dedicated Multidisciplinary Supportive Care Team: Facilitating Early Integration of Palliative Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  38. HILL J, Alhumaid M, Ghosh S, Le A, et al
    Efficiency of Radiotherapy Delivery for Patients With Breast Cancer in a Dedicated Multidisciplinary Palliation Radiation Oncology Clinic.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  39. ALHUMAID M, Hill J, Ghosh S, Watanabe SM, et al
    Comprehensive Assessment of Care Needs During Palliative Radiotherapy Consultation Optimizes Provision of Supportive Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  40. NICHOLS EM, DeCesaris C, Paulosky K, McAvoy SA, et al
    Cardiac Risk Factors in Black Women With Breast Cancer Undergoing Proton Therapy (PBT): Potential for Increased Therapeutic Gain.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  41. MCGUNIGAL M, Bhatt R, Aghdam N
    Sociodemographic Predictors of Stage IV Breast Cancer Presentation in a Vulnerable Patient Population.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  42. BOYCE-FAPPIANO D, Bedrosian I, Shen Y, Lin HY, et al
    Evaluation of Overall Survival and Barriers to Surgery for Breast Cancer Patients Treated Without Surgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  43. GRIFFITH T, Parsons MW, Tward JD, Tao R, et al
    Risk of Secondary Breast Cancer in Female Non-Hodgkin Lymphoma Survivors: 40 Years of Follow-Up Assessed by Treatment Modality.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  44. KINSLOW CJ, Krishnamurthy PB, Sanchez GI, Wang TJC, et al
    Risk of Anaplastic Large Cell Lymphoma After Post-Mastectomy Implant-Reconstruction for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  45. ZHANG Y, Chen F, Jing H, Xu LL, et al
    Radiotherapy Induced Dynamic Changes of Circulating Blood Immune Cell Subsets in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  46. KANG BH, Jang BS, Kim IA
    Radiosensitivity and Immune Cell Infiltration Signature Predict Clinical Outcome of Patients in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) Study Cohort.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  47. CHEN F, Jin JY, Nong Y, Wang W, et al
    Radiation Induced Lymphopenia Can Be Predicted by the Effective Dose to the Circulating Immune Cells (EDIC) in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  48. RAHIMI AS, Kim DN, Leitch M, Gu X, et al
    Early Follow-Up of Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  49. CHEN C, Zheng S, Cao L, Cai G, et al
    Comparison of Prognosis Between Breast Conserving Therapy and Mastectomy in Early Breast Cancer: A Propensity Score Matching Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  50. ZHAI YR, Wen G, Wang SL, Zhang Y, et al
    Systemic Inflammation-Immune Status Score Predicts the Incidence of Radiation Induced Pneumonitis in Patients With Breast Cancer After Whole Breast Irradiation: A Result From Two Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  51. PINNARO P, Takanen S, Landoni V, Vici P, et al
    Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer: 3 Year-Follow-Up of a Phase II Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  52. SMITH AW, Kerns SL, Rowley JP, Moshier E, et al
    Quantifying Risk of Ipsilateral Arm Lymphedema Causing Functional Impairment in Breast Cancer Patients: Results From a Prospective, Multi-Centre International Study of Treatment Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  53. MOON JY, Chang JS, Chung SY, Park RH, et al
    Machine Learning Based Analysis of Heart and Cardiac Substructures for Radiation-Induced Cardiac Toxicity From Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  54. JIANG Z, Diao P, Liang Y, Dai K, et al
    A Light Gradient Boosting Machine-Enabled Early Prediction of Cardiotoxicity for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  55. HALL J, Fried DV, Marks LB, Gupta GP, et al
    Dosimetric and Clinical Factors Associated With Increased Risk of Reconstruction Complications in Patients With Breast Cancer Receiving Post-Mastectomy Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  56. ALLALI S, Beddok A, Servois V, Fourquet A, et al
    Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  57. CHUN J, Chang JS, Park I, Kim JS, et al
    Cardiac Substructure Delineation Based on Synthetic Contrast-Enhanced CT Generation Using Deep Convolutional Neural Network in Breast Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  58. LOAP P, Laki F, Beuzeboc P, Fourquet A, et al
    Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  59. LIAO D, Singh K, Helou J, Fyles A, et al
    Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  60. SUN G, Zhang J, Wang SL, Tang Y, et al
    Tumor-Infiltrating Lymphocytes and Prognosis in Stage I-III Triple-Negative Breast Cancer: A Retrospective Analysis of 258 Patients Treated Without Neoadjuvant Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  61. ZHAO X, Guo N, Ma C, Yan XN, et al
    Mapping of Level I Axillary Lymph Nodes in Patients With Newly Diagnosed Breast Cancer: Optimal Target Delineation and Treatment Techniques in Breast and Level I Axilla Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  62. WARD KA, Muller DA, Dutta SW, Malhi J, et al
    Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Hormone Receptor Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  63. WALLACE AS, Culbert M, Rocque G, Keene KS, et al
    Satisfaction and Regret With Decision Making in Older Women With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  64. SUN G, Wen G, Zhang YJ, Tang Y, et al
    Risk Factors to Identify the Indication for Regional Nodal Irradiation in T1-2N1M0 Breast Cancer: A Joint Analysis of 4243 Real-World Cases From Two Institutions.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  65. SONG Y, Sun G, Wang S, Zhang J, et al
    Quality of Life After Partial or Whole Breast Irradiation After Breast-Conserving Surgery for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  66. SITTENFELD SMC, Zabor E, Hamilton SN, Kuerer HM, et al
    Impact of Post-Mastectomy Radiation Therapy in Women With T1-2N1M0 Breast Cancer With Sentinel Lymph Node Biopsy Alone.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  67. SIT D, Lalani N, Chan EK, Tran E, et al
    Regional Nodal Irradiation for Low-Risk, Node-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  68. SHUKLA U, Langner UW, Tan S, Linshaw D, et al
    Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker vs. Surgical Clips for Targeting Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  69. SEOL SW, Pflederer T, Weller L, Goodman CR, et al
    A Comparison of Outcomes in Early Breast Cancer After External Beam Radiotherapy, Intraoperative Radiotherapy, or Observation: A Retrospective Cohort Study Across a Large Health System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  70. SEOL SW, Weller L, Pflederer T, Goodman CR, et al
    A Comparison of Outcomes in Early-Stage Breast Cancer After External Beam Radiotherapy, Endocrine Therapy, Both, or Neither: A Retrospective Cohort Study Across a Large Health System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  71. SCHLAFSTEIN A, Torres M, Rupji M, Brown G, et al
    Radiotherapy for Breast Cancer, Systemic Inflammation, and Cancer Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  72. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
    Five-Year Report of the Institutional Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  73. RAJ R, Jhawar SR, Stover D, Park KU, et al
    De-Escalation of Radiation Therapy in Patients with cT1-T2 (< 3 cm) N0 HER2+ Breast Cancer Treated With Neoadjuvant Systemic Therapy With Pathologic Complete Response at the Time of Breast Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  74. MARK RJ, Gorman V, Wolski M, McCullough S, et al
    Five Day Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) in Stage 0-II Breast Cancer: A Report of 218 Cases With Up to 39 Month Follow-Up.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  75. OOI KH, Koh WY, Ho F, Tseng MSF, et al
    Efficacy and Safety of Adjuvant Breast Radiation Therapy for Patients With Early-Stage Breast Cancer: A Systematic Review and Network Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  76. MA SJ, Yu B, Oladeru OT, Bartl A, et al
    Evaluation of Adjuvant Radiation and Endocrine Therapy in Elderly Patients with Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  77. LORENZ J, Rizzo M, Patel SA, Kahn ST, et al
    Five-Year Results from a Single Institution Utilizing IORT for Early-Stage Breast Cancer in a Population Comprised of a Majority of African American Women.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  78. GIAP F, Bradley JA, Vega RM, Bates JE, et al
    Treatment of PRIME II Eligible Women With Early-Stage Breast Cancer: A National Cancer Database Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  79. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
    Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  80. CHOUDHURY LS, Moran A, Daly ME, Monjazeb AM, et al
    An Analysis of Daily Setup Variation in Prone Breast Radiation of Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  81. CHEVLI NC, Haque W, Tran KT, Farach AM, et al
    21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  82. CHEN F, Yu H, Nong Y, Jing H, et al
    Risk Factors for Radiation Induced Lymphopenia in Patients With Breast Cancer: Does Radiotherapy Technique Matter?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  83. SYED ANM, Chang H, Hodge W, Reiner SD, et al
    Ethnic and Racial (E/R) Differences in Early-Stage Breast Cancer Patients (Pts) Successfully Treated With Intra-Operative Radiation Therapy (IORT) Using Electronic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  84. MUSHONGA M
    Hypofractionated Radiotherapy for Breast Cancer: Findings From an International ESTRO-GIRO Survey.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  85. LIN JY, Yang X, Miller AH, Godette KD, et al
    A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0-IIIB Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  86. KIM DY, Park E, Heo CY, Jin US, et al
    Hypofractionated vs. Conventional Radiotherapy in Breast Cancer Patients Who Underwent Breast Reconstruction: Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  87. ROSTOM Y, Mahmoud N, Abdelmoneim SE, Shaker M, et al
    Outcomes of Adjuvant Hypofractionated Radiotherapy in the Treatment of Post-Mastectomy Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  88. ZHAO X, Xuan L, Yin J, Tang Y, et al
    Radiotherapy in Breast Cancer Patients With Isolated Regional Recurrence After Mastectomy: A Joint Analysis of 144 Cases From Two Institutions.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  89. WANG M, Chen J, Qi WX, Cao L, et al
    Using Inflammatory Blood Markers as Useful Prognostic Factors in Patients Undergoing Neo-Adjuvant Therapy for Stage II-III Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  90. PURSWANI J, Oh C, Xiao J, Barbee D, et al
    Boost to Unresectable Nodal Disease in Locally Advanced Breast Cancer: Outcomes and Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  91. NARAYAN P, Flynn J, Zhang Z, Gillespie EF, et al
    Perineural Invasion as a Risk Factor for Locoregional Recurrence of Invasive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  92. KIM BH, Cho MJ, Kwon J
    Potential Intrinsic Subtype Dependence on the Association Between Metformin Use and Survival in Surgically Resected Breast Cancer: A Korean National Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  93. KIM JK, Karp JM, Gerber NK
    Isolated Tumor Cells and Micrometastatic Nodal Disease in Breast Cancer Patients After Neoadjuvant Chemotherapy: Is Post Mastectomy Radiation Therapy Indicated?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  94. ANDRING LM, Diao K, Sun SX, Patel MM, et al
    Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  95. CHU CN, Chan KHC, Wu RSC
    FR-101 Dressing May Alleviate Radiation-Irritated Skin After Radiotherapy in Breast Cancer Patients - A Pilot Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  96. MO A, Chung J, Eichler J, Yukelis S, et al
    Breast Cancer Survivorship Care During the COVID-19 Pandemic Within an Urban New York Hospital System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  97. YUSUF MB, Pan J, Rai SN, Eldredge-Hindy HB, et al
    Financial Toxicity in Women with Breast Cancer Receiving Radiotherapy: Final Results of a Prospective Observational Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  98. WEISS M, Danese S, Ruiz KA, Kjelstrom S, et al
    A Survey of Breast Cancer Patients' Use of Cannabis During Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  99. YU J, Wroe A, Acosta M, Fagundes MA, et al
    Impact of Dose Calculation Algorithm on Skin Dose for Breast Cancer Treated With Intensity Modulated Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  100. DAI Z, Liang X, Zhu L, Tan J, et al
    Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  101. BYUN HK, Chang JS, Choi MS, Chun J, et al
    Evaluation of Deep Learning-Based Auto-Segmentation of Organs-at-Risk for Breast Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  102. LOAP P, Loirat D, Berger F, Rodrigues M, et al
    One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  103. SERRA D, Fleishman S, White C, Welsh C, et al
    Effectiveness of Traditional Acupuncture in Reducing the Severity of Hot Flashes Reported by Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  104. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
    Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  105. NELSON CJ, Ahern T, Brennan S, Kerrigan C, et al
    A Pilot Study to Quantify Breast Lymphedema for Patients Undergoing Breast Conserving Therapy (BCT) for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  106. MANKUZHY N, Grzywacz VP 2nd, Quinn TJ, Jawad MS, et al
    Thirty-Year Single Institution Experience of Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  107. CHEN S, Sun G, Wang S, Fang H, et al
    Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  108. FORSTER T, Hommertgen A, Hafner MF, Arians N, et al
    Quality of Life After Simultaneously Integrated Boost With Intensity-Modulated vs. Conventional Radiotherapy Followed by Sequential Boost for Adjuvant Treatment of Breast Cancer: 2-Year Results of the Multicenter Randomized IMRT-MC2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  109. BELLON JR, Tayob N, Burstein HJ, Partridge A, et al
    Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  110. CHOI IJ, Khan AJ, Mah D, McCormick B, et al
    Proton Reirradiation for Recurrent or New Primary Breast Cancer in the Setting of Prior Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  111. DIAA M, Mohammmed T, Abd Elshaheed WH, Bayomy M, et al
    The Impact of Regional Nodal Irradiation on the Outcomes After Neoadjuvant Chemotherapy in Node Positive Breast Cancer Patients With ypN0: Interim Analysis of a Prospective Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  112. DIAO K, Andring LM, Barcenas CH, Singh P, et al
    Outcomes After Multimodality Therapy in Modern Breast Cancer Patients Presenting With Clinical N3c Supraclavicular Node Involvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  113. NAOUM GE, Ioakeim-Ioannidou M, Shui AM, Salama L, et al
    Analysis of Radiation Modality and Timing on Complication Rates in Breast Cancer Patients Receiving Two-Stage Expander/Implant Reconstruction.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  114. KIM YB, Byun HK, Kim DY, Ahn SJ, et al
    Elective Internal Mammary Node Irradiation in Women With Node-Positive Breast Cancer: Results of a Randomized, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  115. JAGSI R, Griffith KA, Vicini FA, Abu-Isa E, et al
    Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
    Int J Radiat Oncol Biol Phys. 2021 Oct 27. pii: S0360-3016(21)02918.
    PubMed     Abstract available


  116. RAHIMI A, Simmons A, Kim DN, Leitch M, et al
    Preliminary Results of Multi-Institutional Phase I Dose Escalation Trial Using Single Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer: Dose Escalated Single Fraction Stereotactic PBI.
    Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02916.
    PubMed     Abstract available


  117. SAULSBERRY L, Liao C, Huo D
    Hypofractionated Radiotherapy for Breast Cancer: Financial Risk and Expenditures in the U.S. 2008-2017: Expenditure of Hypofractionated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 9. pii: S0360-3016(21)02901.
    PubMed     Abstract available


  118. CUTTINO LW, McCall L, Kubicky C, Ballman KV, et al
    The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02872.
    PubMed    


  119. JAGSI R, Griffith KA, Moran JM, Matuszak MM, et al
    Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02871.
    PubMed     Abstract available


  120. VAN VELZEN SGM, Gal R, Teske AJ, van der Leij F, et al
    AI-based radiation dose quantification for estimation of heart disease risk in breast cancer survivors after radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 5. pii: S0360-3016(21)02791.
    PubMed     Abstract available


  121. KIM DY, Park E, Heo CY, Jin US, et al
    Influence of Hypofractionated versus Conventional Fractionated Postmastectomy Radiotherapy in Breast Cancer Patients with Reconstruction.
    Int J Radiat Oncol Biol Phys. 2021 Oct 2. pii: S0360-3016(21)02835.
    PubMed     Abstract available


  122. WENG JK, Lei X, Schlembach P, Bloom ES, et al
    Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111:360-370.
    PubMed     Abstract available


    September 2021
  123. VAN VELZEN SGM, Bruns S, Wolterink JM, Leiner T, et al
    AI-based quantification of planned radiotherapy dose to cardiac structures and coronary arteries in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2021 Sep 18. pii: S0360-3016(21)02792.
    PubMed     Abstract available


  124. SPEERS C, Murthy VL, Walker EM, Glide-Hurst CK, et al
    Cardiac MRI and blood biomarkers for evaluation of radiation-induced cardiotoxicity in breast cancer patients: results of a phase II clinical trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 9. pii: S0360-3016(21)02732.
    PubMed     Abstract available


  125. SPEERS CW, Mutter RW
    When Old Becomes New-Repurposing Cytotoxic Chemotherapy With Radiation to Improve Outcomes in Women With Aggressive Forms of Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:53-55.
    PubMed    


    August 2021
  126. DIAO K, Andring LM, Barcenas CH, Singh P, et al
    Contemporary Outcomes after Multimodality Therapy in Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Node Involvement.
    Int J Radiat Oncol Biol Phys. 2021 Aug 20. pii: S0360-3016(21)02714.
    PubMed     Abstract available


  127. BRADLEY JA, Strauss JB, Bellon JR
    Postmastectomy Bolus: Urban Legend or Sound Practice?
    Int J Radiat Oncol Biol Phys. 2021;110:1370-1372.
    PubMed    


  128. JACOBSON G, Lawrence YR, Appel S, Weiss I, et al
    Benefits of Continuous Positive Airway Pressure (CPAP) During Radiation Therapy: A Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:1466-1472.
    PubMed     Abstract available


  129. MANUKIAN G, Kivolowitz C, DeAngelis T, Shastri AA, et al
    Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
    Int J Radiat Oncol Biol Phys. 2021;110:1341-1349.
    PubMed     Abstract available


  130. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


  131. NICHOL A, Narinesingh D, Raman S, Germain F, et al
    The Effect of Bolus on Local Control for Patients Treated With Mastectomy and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1360-1369.
    PubMed     Abstract available


    July 2021
  132. LAPEN K, Sabol C, Tin AL, Lynch K, et al
    Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes (ePROs) for patients undergoing radiation therapy for breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jul 24. pii: S0360-3016(21)02562.
    PubMed     Abstract available


  133. SURA K, Chen PY
    Determining the Optimal Treatment of Locally Advanced Breast Cancer With Sequelae of Dermatomyositis.
    Int J Radiat Oncol Biol Phys. 2021;110:940-941.
    PubMed    


  134. RODIN D, Strauss JB, R Bellon J
    "Standard" Fractionation for Breast Cancer is No Longer Standard.
    Int J Radiat Oncol Biol Phys. 2021;110:925-927.
    PubMed    


  135. NAOUM GE, Taghian AG
    Regional Lymph Nodes Radiation and Breast Cancer Related Lymphedema: Where We Stand.
    Int J Radiat Oncol Biol Phys. 2021;110:1159-1160.
    PubMed    


  136. BOSMA SCJ, van der Leij F, Elkhuizen PHM, Vreeswijk S, et al
    Evaluation of Early Response to Preoperative Accelerated Partial Breast Irradiation (PAPBI) by Histopathology, Magnetic Resonance Imaging, and 18F-fluorodexoyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT).
    Int J Radiat Oncol Biol Phys. 2021;110:1151-1158.
    PubMed     Abstract available


  137. SMALL W JR, Pugh SL, Wagner LI, Kirshner J, et al
    Psychological Treatment for Patients Receiving Radiation: Results of NRG Oncology/RTOG 0841.
    Int J Radiat Oncol Biol Phys. 2021;110:962-972.
    PubMed     Abstract available


  138. KIM SW, Cho WK, Choi DH, Kim H, et al
    What Is High-Risk Breast Cancer with Pathologically Negative Lymph Nodes for Regional Recurrence?
    Int J Radiat Oncol Biol Phys. 2021 Jul 13. pii: S0360-3016(21)00874.
    PubMed     Abstract available


  139. PURSWANI JM, Oh C, Jaros B, Sandigursky S, et al
    Breast Conservation in Women with Autoimmune Disease: The Role of Active Autoimmune Disease and Hypofractionation on Acute and Late Toxicity in a Case-Controlled Series.
    Int J Radiat Oncol Biol Phys. 2021;110:783-791.
    PubMed     Abstract available


    June 2021
  140. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
    Final Analysis of a Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jun 25. pii: S0360-3016(21)00744.
    PubMed     Abstract available


  141. HANNOUN-LEVI JM, Gal J, Van Limbergen E, Chand ME, et al
    Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database.
    Int J Radiat Oncol Biol Phys. 2021;110:452-461.
    PubMed     Abstract available


  142. LIU HC, Viswanath DI, Pesaresi F, Xu Y, et al
    Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1.
    Int J Radiat Oncol Biol Phys. 2021;110:492-506.
    PubMed     Abstract available


    May 2021
  143. MUTTER RW, Choi JI, Jimenez RB, Kirova YM, et al
    Proton Therapy for Breast Cancer: A Consensus Statement from the Particle Therapy Cooperative Group (PTCOG) Breast Cancer Subcommittee.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00652.
    PubMed     Abstract available


  144. GERBER NK, Shao H, Chadha M, Deb P, et al
    Radiation without endocrine therapy in older women with stage I estrogen-receptor (ER) positive breast cancer is not associated with a higher risk of second breast cancer events.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00457.
    PubMed     Abstract available


    April 2021
  145. HANNOUN-LEVI JM, Montagne L, Sumodhee S, Schiappa R, et al
    APBI versus ultra APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity.
    Int J Radiat Oncol Biol Phys. 2021 Apr 5. pii: S0360-3016(21)00314.
    PubMed     Abstract available


  146. BOUTRUS RR, El Sherif S, Abdelazim Y, Bayomy M, et al
    Once Daily Versus Twice Daily External Beam Accelerated Partial Breast Irradiation: A Randomized Prospective Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1296-1300.
    PubMed     Abstract available


  147. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available


  148. KUMAR KA, Balazy KE, Gutkin PM, Jacobson CE, et al
    Association Between Patient Education Videos and Knowledge of Radiation Treatment.
    Int J Radiat Oncol Biol Phys. 2021;109:1165-1175.
    PubMed     Abstract available


  149. JARVIS LA, Hachadorian RL, Jermyn M, Bruza P, et al
    Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery.
    Int J Radiat Oncol Biol Phys. 2021;109:1627-1637.
    PubMed     Abstract available


    March 2021
  150. POLGAR C, Major T, Takacsi-Nagy Z, Fodor J, et al
    Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study.
    Int J Radiat Oncol Biol Phys. 2021;109:998-1006.
    PubMed     Abstract available


  151. BELLON JR, Chen YH, Rees R, Taghian AG, et al
    A phase I dose-escalation trial of radiation therapy and concurrent cisplatin for stage II and III triple-negative breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00242.
    PubMed     Abstract available


  152. VAN DEN BOGAARD VAB, Spoor DS, van der Schaaf A, van Dijk LV, et al
    The Importance of Radiation Dose to the Atherosclerotic Plaque in the Left Anterior Descending Coronary Artery for Radiation-Induced Cardiac Toxicity of Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00244.
    PubMed     Abstract available


  153. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  154. DE PAULA U, D'Angelillo RM, Andrulli AD, Apicella G, et al
    Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:678-687.
    PubMed     Abstract available


    February 2021
  155. CHANG WI, Han MG, Kang MH, Park JM, et al
    PI3Kalphadelta Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
    Int J Radiat Oncol Biol Phys. 2021 Feb 25. pii: S0360-3016(21)00085.
    PubMed     Abstract available


  156. POLGAR C, Strnad V, Hannoun-Levi JM, Major T, et al
    Reply to the Editor - Do we think seriously that a single shot of 5 Gy intraoperative irradiation at 1 cm is able to avoid any local recurrence or non-breast cancer death after breast-conserving surgery?
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00198.
    PubMed    


  157. VAIDYA JS, Bulsara M, Sperk E, Massarut S, et al
    TARGIT-IORT during lumpectomy for breast cancer - better for patients than other PBI approaches.
    Int J Radiat Oncol Biol Phys. 2021 Feb 24. pii: S0360-3016(21)00199.
    PubMed    


  158. WANG B, Huang X, Liang H, Yang H, et al
    PLK1 inhibition sensitizes breast cancer cells to radiation via suppressing autophagy.
    Int J Radiat Oncol Biol Phys. 2021 Feb 20. pii: S0360-3016(21)00203.
    PubMed     Abstract available


  159. MCDUFF SGR, Bellon JR, Shannon KM, Gadd MA, et al
    ATM Variants in Breast Cancer: Implications for Breast Radiotherapy Treatment Recommendations.
    Int J Radiat Oncol Biol Phys. 2021 Feb 2. pii: S0360-3016(21)00119.
    PubMed     Abstract available


  160. PINKAWA M
    Spinal Cord Reirradiation:Balancing Benefit Against Risks.
    Int J Radiat Oncol Biol Phys. 2021;109:312-313.
    PubMed    


  161. PASALIC D, Strom EA, Allen PK, Williamson TD, et al
    Proton Accelerated Partial Breast Irradiation: Clinical Outcomes at a Planned Interim Analysis of a Prospective Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:441-448.
    PubMed     Abstract available


    January 2021
  162. RAHIMI A, Morgan HE, Kim DW, Zhang Y, et al
    Cosmetic outcomes of a phase I dose escalation study of 5-fraction stereotactic partial breast irradiation for early stage breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 18. pii: S0360-3016(21)00067.
    PubMed     Abstract available


  163. CHUNG SY, Oh J, Chang JS, Shin J, et al
    Risk of Cardiac Disease in Breast Cancer Patients: Impact of Patient-Specific Factors and Individual Heart Dose from Three-Dimensional Radiotherapy Planning.
    Int J Radiat Oncol Biol Phys. 2021 Jan 6. pii: S0360-3016(21)00003.
    PubMed     Abstract available


  164. CHOI SH, Chang JS, Son NH, Hong CS, et al
    Risk of Hypothyroidism in Women after Radiotherapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jan 4. pii: S0360-3016(20)34743.
    PubMed     Abstract available



  165. Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020
    Int J Radiat Oncol Biol Phys. 2021;109:303.
    PubMed    


  166. POPPE MM, Khan AJ
    In Reply to Dyer et al.
    Int J Radiat Oncol Biol Phys. 2021;109:301-302.
    PubMed    


  167. DYER BA, Flanagan MR, Said HK, Kim J, et al
    In Regard to Poppe et al.
    Int J Radiat Oncol Biol Phys. 2021;109:300-301.
    PubMed    


  168. TOM MC, Sittenfeld SMC, Shah C, Bauer-Nilsen K, et al
    Use of a Radiation Tumor Bed Boost After Breast-Conserving Surgery and Whole-Breast Irradiation: Time Trends and Correlates.
    Int J Radiat Oncol Biol Phys. 2021;109:273-280.
    PubMed     Abstract available


    December 2020
  169. CLASEN SC, Shou H, Freedman G, Plastaras JP, et al
    Early cardiac effects of contemporary radiation therapy in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34654.
    PubMed     Abstract available


  170. VASMEL JE, Vreuls CP, Manson QF, Charaghvandi RK, et al
    Tumor infiltrating lymphocytes in low-risk breast cancer patients treated with single dose pre-operative partial breast irradiation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34655.
    PubMed     Abstract available


  171. HORNER-RIEBER J, Forster T, Hommertgen A, Haefner MF, et al
    Intensity-modulated radiotherapy (IMRT) with simultaneously integrated boost shortens treatment time and is non-inferior to conventional radiotherapy followed by sequential boost in adjuvant breast cancer treatment: results of a large randomized phase
    Int J Radiat Oncol Biol Phys. 2020 Dec 12. pii: S0360-3016(20)34651.
    PubMed     Abstract available


  172. FRANCIS DM, Brower JV
    Post-Mastectomy Radiation After Immediate Reconstruction for Multifocal Early-Stage Breast Cancer; to Irradiate or Not?
    Int J Radiat Oncol Biol Phys. 2020;108:1129-1130.
    PubMed    


  173. ZEIDAN YH, Poortmans P
    Don't Miss the Devil in the Details.
    Int J Radiat Oncol Biol Phys. 2020;108:1133.
    PubMed    


  174. MCCALL AR, Son CH
    Young and High Risk.
    Int J Radiat Oncol Biol Phys. 2020;108:1132-1133.
    PubMed    


  175. ROYCE TJ, Marks LB
    Balancing the Benefits and Harms of Postmastectomy Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1131.
    PubMed    


  176. NAOUM GE, Taghian AG
    Complications May Outweigh the Benefits.
    Int J Radiat Oncol Biol Phys. 2020;108:1131-1132.
    PubMed    


  177. MUTTER RW, Hepel JT
    Accelerated Partial Breast Radiation: Information on Dose, Volume, Fractionation, and Efficacy from Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2020;108:1123-1128.
    PubMed    


  178. HEPEL JT, Leonard KL, Sha S, Graves TA, et al
    Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
    Int J Radiat Oncol Biol Phys. 2020;108:1143-1149.
    PubMed     Abstract available


  179. DETAPPE A, Mathieu C, Jin C, Agius MP, et al
    Anti-MUC1-C Antibody-Conjugated Nanoparticles Potentiate the Efficacy of Fractionated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1380-1389.
    PubMed     Abstract available


    November 2020
  180. BERNSTEIN-MOLHO R, Laitman Y, Galper S, Jacobson G, et al
    Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers.
    Int J Radiat Oncol Biol Phys. 2020 Nov 28. pii: S0360-3016(20)34598.
    PubMed     Abstract available


  181. SHI J, Xu K, Keyvanloo A, Udayakumar TS, et al
    A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;108:1063-1072.
    PubMed     Abstract available


  182. SHUMWAY DA, Motomura A, Griffith KA, Hayman JA, et al
    Patient Perceptions in a Nonblinded Randomized Trial of Radiation Therapy Technologies: A Novel Survey Study Exploring Therapeutic Misconception.
    Int J Radiat Oncol Biol Phys. 2020;108:867-875.
    PubMed     Abstract available


    October 2020
  183. BOYAGES J, Vicini FA, Shah C, Koelmeyer LA, et al
    The risk of subclinical breast cancer-related lymphedema by the extent of axillary surgery and regional node irradiation-a randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2020 Oct 27. pii: S0360-3016(20)34440.
    PubMed     Abstract available


  184. KRISHNAN S, Narayan HK, Freedman G, Plastaras JP, et al
    Early Changes in Physical Activity and Quality of Life with Thoracic Radiation Therapy in Breast Cancer, Lung Cancer, and Lymphoma.
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34406.
    PubMed     Abstract available


  185. BILLENA C, Wilgucki M, Flynn J, Modlin L, et al
    10-Year Breast Cancer Outcomes in Women
    Int J Radiat Oncol Biol Phys. 2020 Oct 24. pii: S0360-3016(20)34437.
    PubMed     Abstract available


  186. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


    September 2020
  187. LOAP P, Loirat D, Berger F, Ricci F, et al
    Combination of Olaparib and radiotherapy for triple negative breast cancer: preliminary results of the RADIOPARP phase I trial.
    Int J Radiat Oncol Biol Phys. 2020 Sep 21. pii: S0360-3016(20)34304.
    PubMed     Abstract available


    August 2020
  188. LAUCIS AM, Jagsi R, Griffith KA, Dominello MM, et al
    The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:949-958.
    PubMed     Abstract available


    July 2020
  189. POPPE MM, Yehia ZA, Baker C, Goyal S, et al
    5-Year Update of a Multi-Institution, Prospective Phase 2 Hypofractionated Postmastectomy Radiation Therapy Trial.
    Int J Radiat Oncol Biol Phys. 2020;107:694-700.
    PubMed     Abstract available


  190. LALANI N, Jimenez RB, Yeap B
    Understanding Propensity Score Analyses.
    Int J Radiat Oncol Biol Phys. 2020;107:404-407.
    PubMed    


    June 2020
  191. STRAUSS JB
    Extensive Lymphovascular Invasion Warrants Extensive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:234-235.
    PubMed    


  192. SHAH C, Vicini F
    Early Stage, But Not So Routine.
    Int J Radiat Oncol Biol Phys. 2020;107:233.
    PubMed    


  193. HARA JH, Son CH
    From Chemo Rejection to Regional Radiation: A Post-Mastectomy Dilemma.
    Int J Radiat Oncol Biol Phys. 2020;107:232.
    PubMed    


  194. OLADERU OT, Ho AY
    The Local Control of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:233-234.
    PubMed    


    May 2020
  195. NAOUM GE, Taghian AG
    In Reply to Kim et al.
    Int J Radiat Oncol Biol Phys. 2020;107:224.
    PubMed    


  196. KIM J, Chang JS, Lee DW, Song SY, et al
    In Regard to Naoum et al.
    Int J Radiat Oncol Biol Phys. 2020;107:223.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: